TY - JOUR
AU - J. Hwee
AU - L. Harper
AU - Q. Fu
AU - K. Nirantharakumar
AU - G. Mu
AU - R. Jakes
AD - GSK, Epidemiology, Mississauga, ON, Canada.
University of Birmingham, Institute of Applied Health Research, Birmingham, UK.
GSK, Value Evidence Outcomes, Collegeville, PA, USA.
GSK, Epidemiology, London, UK.
AN - 38746859
BT - ERJ Open Res
C2 - PMC11089387 and own stocks/shares with GSK. L. Harper has received speaking fees, consulting fees or grant/research support from Viopharm, GSK, Roche and MSD. K. Nirantharakumar has been awarded academic institution research grants from NIHR, UKRI/MRC, Kennedy Trust for Rheumatology Research, Health Data Research UK, Wellcome Trust, European Regional Development Fund, Institute for Global Innovation, Boehringer Ingelheim, Action Against Macular Degeneration Charity, Midlands Neuroscience Teaching and Development Funds, South Asian Health Foundation, Vifor Pharma, College of Police, and CSL Behring; consulting fees from BI, Sanofi, CEGEDIM and MSD; and holds a leadership/fiduciary role with NICST, a charity, and OpenClinical, a social enterprise.
DO - 10.1183/23120541.00430-2023
DP - NLM
ET - 2024/05/15
LA - eng
M1 - 3
N1 - 2312-0541
Hwee, Jeremiah
Orcid: 0000-0002-2623-7706
Harper, Lorraine
Fu, Qinggong
Nirantharakumar, Krishnarajah
Mu, George
Jakes, Rupert W
Orcid: 0000-0002-3837-8063
Journal Article
England
ERJ Open Res. 2024 May 13;10(3):00430-2023. doi: 10.1183/23120541.00430-2023. eCollection 2024 May.
PY - 2024
SN - 2312-0541 (Print)
2312-0541
T2 - ERJ Open Res
TI - Prevalence, incidence and healthcare burden of eosinophilic granulomatosis with polyangiitis in the UK
VL - 10
ER -